To Get Help Now
Click Here
Today's Date:

Actos Faces San Francisco Lawsuit For Failure To Warn

AddThis Social Bookmark Button

A federal lawsuit has been filed against Takeda Pharmaceuticals and Eli Lilly and Company for not warning consumers about the increased risk of bladder cancer when Actos is used long-term.

According to the lawsuit, the FDA issued a safety alert after an increased risk of bladder cancer was discovered. European studies showed similar findings, and France and Germany restricted the use of Actos, the Sun Herald reported.

Pioglitazone is a type 2 diabetes drug sold under the name Actos. The June 15, 2011 FDA safety alert said that “”the risk of bladder cancer increased with increasing dose and duration of pioglitazone use. Compared to never being exposed to pioglitazone, a duration of pioglitazone therapy longer than 12 months was associated with a 40% increase in risk.”

An attorney for the plaintiff was quoted by the Sun Herald as saying “Prescription drug manufacturers are required to issue warnings about the possible risks of negative side effects from their products. When a manufacturer decides not to provide full disclosure of the potential risks from a medication, doctors and patients cannot make informed decisions about what drug is right for them, and as a result, people suffer injuries unnecessarily.” disclaimer: This article: Actos Faces San Francisco Lawsuit For Failure To Warn was posted on Tuesday, August 23rd, 2011 at 7:16 pm at and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.